Company Filing History:
Years Active: 2019-2020
Title: Sylvie Perret: Innovator in Recombinant Protein Production
Introduction
Sylvie Perret is a prominent inventor based in Montreal, Canada. She has made significant contributions to the field of biotechnology, particularly in the production of recombinant proteins. With two patents to her name, her work has the potential to impact various applications in medicine and research.
Latest Patents
One of her latest patents focuses on the enhanced production of recombinant proteins by transient transfection of suspension-growing mammalian cells. This innovative process involves the use of suspension-grown human embryonic kidney cells, specifically the 293 cell line and its genetic variants. By utilizing polyethylenimine (PEI) as a transfection reagent, the process allows for high expression levels of proteins in a short period. It combines cell growth, transfection, and protein expression in a single step without changing the culture medium. This method is scalable, compatible with continuous production processes, and well-suited for high-throughput production of milligram quantities of recombinant proteins.
Career Highlights
Sylvie Perret is currently affiliated with the National Research Council of Canada, where she continues her research and development in biotechnology. Her work has garnered attention for its innovative approach to protein production, which is crucial for various scientific and medical applications.
Collaborations
Some of her notable coworkers include Yves Durocher and Amine A Kamen, who have collaborated with her on various projects related to recombinant protein production.
Conclusion
Sylvie Perret's contributions to the field of biotechnology, particularly in recombinant protein production, highlight her role as an influential inventor. Her innovative processes have the potential to advance research and applications in medicine, showcasing the importance of her work in the scientific community.